NCT05696509View on ClinicalTrials.gov

Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

January 3, 2020

Primary Completion Date

October 13, 2022

Study Completion Date

October 16, 2022

Conditions
Mitral Valve InsufficiencyAortic Valve Insufficiency
Interventions
DRUG

Propofol

To maintain anaesthesia in Group 1 P, propofol was used as an anaesthetic in a dose of 4-6 mg/kg/h intravenously on a perfusor.

DRUG

Isoflurane

Isoflurane was used as an anaesthetic in a dose of - 1.1-1.2 MAC

DRUG

Sevoflurane

sevoflurane was used as an anaesthetic in a dose of - 1.7-1.9 MAC

Trial Locations (1)

0.00001

Bekzat, Astana

All Listed Sponsors
lead

Astana Medical University

OTHER

NCT05696509 - Influence of Anesthetics on Clinical Outcome in Mitral and Aortic Valve Replacement in Adults | Biotech Hunter | Biotech Hunter